Visceral and subcutaneous fat as new independent predictive factors of survival in locally advanced gastric carcinoma patients treated with neo-adjuvant chemotherapy

Journal of Cancer Research and Clinical Oncology

Volumn 141, Issue 7, 2015, Pages 1237-1247

  Li, Xiao Ting ^a   Tang, Lei ^a   Chen, Ying ^a   Li, Yan Ling ^a   Zhang, Xiao Peng ^a   Sun, Ying Shi ^a  

^a PEKING UNIVERSITY CANCER HOSPITAL AND INSTITUTE   (China)

Author keywords

Computed tomography; Fat; Gastric cancer; Survival

Indexed keywords

ANTINEOPLASTIC AGENT;

ADENOCARCINOMA; ADJUVANT THERAPY; AGED; CARCINOMA, SIGNET RING CELL; COMPUTER ASSISTED TOMOGRAPHY; DISEASE COURSE; FEMALE; HUMAN; INTRAABDOMINAL FAT; MALE; MIDDLE AGED; MORTALITY; PATHOLOGY; PROGNOSIS; RADIOGRAPHY; RETROSPECTIVE STUDY; STOMACH NEOPLASMS; SUBCUTANEOUS FAT; SURVIVAL;

ADENOCARCINOMA; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SIGNET RING CELL; DISEASE PROGRESSION; FEMALE; HUMANS; INTRA-ABDOMINAL FAT; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; PROGNOSIS; RETROSPECTIVE STUDIES; STOMACH NEOPLASMS; SUBCUTANEOUS FAT; SURVIVAL ANALYSIS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84938505141     PISSN: 01715216     EISSN: 14321335     Source Type: Journal    
DOI: 10.1007/s00432-014-1893-y     Document Type: Article

References (34)

1. Ajani JA et al (2013) Gastric cancer, version 2.2013: featured updates to the NCCN Guidelines. J Natl Compr Cancer Netw JNCCN 11:531–546
2. Aleman JO, Eusebi LH, Ricciardiello L, Patidar K, Sanyal AJ, Holt PR (2014) Mechanisms of obesity-induced gastrointestinal neoplasia. Gastroenterology 146:357–373. doi:10.1053/j.gastro.2013.11.051
3. Bazzocchi A, Diano D, Battista G (2012) How fat is fat? Lancet 380:e1. doi:10.1016/S0140-6736(11)61925-9
4. Bianchini F, Kaaks R, Vainio H (2002) Overweight, obesity, and cancer risk. Lancet Oncol 3:565–574
5. Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ (2003) Overweight, obesity, and mortality from cancer in a prospectively studied cohort of US adults. N Engl J Med 348:1625–1638. doi:10.1056/NEJMoa021423
6. Cao Y (2007) Angiogenesis modulates adipogenesis and obesity. J Clin Investig 117:2362–2368. doi:10.1172/JCI32239
7. Cecchini S, Cavazzini E, Marchesi F, Sarli L, Roncoroni L (2011) Computed tomography volumetric fat parameters versus body mass index for predicting short-term outcomes of colon surgery. World J Surg 35:415–423. doi:10.1007/s00268-010-0888-3
8. Demark-Wahnefried W et al (2012) The role of obesity in cancer survival and recurrence. Cancer Epidemiol Biomarkers Prev 21:1244–1259. doi:10.1158/1055-9965.EPI-12-0485
9. Fox CS et al (2007) Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study. Circulation 116:39–48. doi:10.1161/CIRCULATIONAHA.106.675355
10. Gaujoux S et al (2012) Impact of obesity and body fat distribution on survival after pancreaticoduodenectomy for pancreatic adenocarcinoma. Ann Surg Oncol 19:2908–2916. doi:10.1245/s10434-012-2301-y
11. Grabsch HI, Tan P (2013) Gastric cancer pathology and underlying molecular mechanisms. Dig Surg 30:150–158. doi:10.1159/000350876
12. Griggs JJ, Sabel MS (2008) Obesity and cancer treatment: weighing the evidence. J Clin Oncol 26:4060–4062. doi:10.1200/JCO.2008.17.4250
13. Guiu B et al (2010) Visceral fat area is an independent predictive biomarker of outcome after first-line bevacizumab-based treatment in metastatic colorectal cancer. Gut 59:341–347. doi:10.1136/gut.2009.188946
14. House MG et al (2008) Preoperative predictors for complications after pancreaticoduodenectomy: impact of BMI and body fat distribution. J Gastrointest Surg 12:270–278. doi:10.1007/s11605-007-0421-7
15. Hsing AW et al (2000) Body size and prostate cancer: a population-based case–control study in China. Cancer Epidemiol Biomarkers Prev 9:1335–1341
16. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011) Global cancer statistics. CA Cancer J Clin 61:69–90. doi:10.3322/caac.20107
17. Jung M et al (2014) Perirenal fat surface area as a risk factor for morbidity after elective colorectal surgery. Dis Colon Rectum 57:201–209. doi:10.1097/DCR.0000000000000029
18. Ladoire S et al (2011) Visceral fat area as a new independent predictive factor of survival in patients with metastatic renal cell carcinoma treated with antiangiogenic agents. Oncologist 16:71–81. doi:10.1634/theoncologist.2010-0227
19. Li D, Morris JS, Liu J, Hassan MM, Day RS, Bondy ML, Abbruzzese JL (2009) Body mass index and risk, age of onset, and survival in patients with pancreatic cancer. JAMA 301:2553–2562. doi:10.1001/jama.2009.886
20. Maurovich-Horvat P, Massaro J, Fox CS, Moselewski F, O’Donnell CJ, Hoffmann U (2007) Comparison of anthropometric, area- and volume-based assessment of abdominal subcutaneous and visceral adipose tissue volumes using multi-detector computed tomography. Int J Obes 31:500–506. doi:10.1038/sj.ijo.0803454
21. Medina-Franco H, Contreras-Saldivar A, Ramos-De La Medina A, Palacios-Sanchez P, Cortes-Gonzalez R, Ugarte JA (2004) Surgery for stage IV gastric cancer. Am J Surg 187:543–546. doi:10.1016/j.amjsurg.2003.12.045
22. Miyazawa-Hoshimoto S, Takahashi K, Bujo H, Hashimoto N, Yagui K, Saito Y (2005) Roles of degree of fat deposition and its localization on VEGF expression in adipocytes. Am J Physiol Endocrinol Metab 288:E1128–E1136. doi:10.1152/ajpendo.00003.2004
23. Moore LL, Bradlee ML, Singer MR, Splansky GL, Proctor MH, Ellison RC, Kreger BE (2004) BMI and waist circumference as predictors of lifetime colon cancer risk in Framingham Study adults. Int J Obes Relat Metab Disord 28:559–567. doi:10.1038/sj.ijo.0802606
24. Ohki T et al (2009) Visceral fat accumulation is an independent risk factor for hepatocellular carcinoma recurrence after curative treatment in patients with suspected NASH. Gut 58:839–844. doi:10.1136/gut.2008.164053
25. Piazuelo MB, Correa P (2013) Gastric cancer: overview. Colomb Med 44:192–201
26. Pischon T et al (2006) Body size and risk of colon and rectal cancer in the European Prospective Investigation Into Cancer and Nutrition (EPIC). J Natl Cancer Inst 98:920–931. doi:10.1093/jnci/djj246
27. Renehan AG, Tyson M, Egger M, Heller RF, Zwahlen M (2008) Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet 371:569–578. doi:10.1016/S0140-6736(08)60269-X
28. Sakai T, Maekawa T, Mikami K, Kuramochi H, Noda S (2009) Short-term outcomes of colon surgery are better predicted by fat volumetric parameters than by the BMI. This study has provided new elements for discussion on the impact of visceral and subcutaneous adiposity in laparoscopic and traditional colon surgery. Int Surg 94:370–372. doi:10.1007/s00268-010-0888-3
29. Smith DD, Schwarz RR, Schwarz RE (2005) Impact of total lymph node count on staging and survival after gastrectomy for gastric cancer: data from a large US-population database. J Clin Oncol 23:7114–7124. doi:10.1200/JCO.2005.14.621
30. Tokunaga K, Matsuzawa Y, Ishikawa K, Tarui S (1983) A novel technique for the determination of body fat by computed tomography. Int J Obes 7:437–445
31. Tuma RS et al (2006) Sometimes size doesn’t matter: reevaluating RECIST and tumor response rate endpoints. J Natl Cancer Inst 98:1272–1274
32. Wagner AD, Grothe W, Haerting J, Kleber G, Grothey A, Fleig WE (2006) Chemotherapy in advanced gastric cancer: a systematic review and meta-analysis based on aggregate data. J Clin Oncol 24:2903–2909. doi:10.1200/JCO.2005.05.0245
33. Yoshizumi T et al (1999) Abdominal fat: standardized technique for measurement at CT. Radiology 211:283–286. doi:10.1148/radiology.211.1.r99ap15283
34. Yuan C et al (2013) Prediagnostic body mass index and pancreatic cancer survival. J Clin Oncol 31:4229–4234. doi:10.1200/JCO.2013.51.7532